Company
Headquarters: Mississauga, ON, Canada
C$804.8 Million
CAD as of July 1, 2023
US$607.4 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. TerrAscend Corp. was incorporated in 2017 and is based in Mississauga, Canada.
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | C$247.8 M |
| EBITDA | C$37.3 M |
| Gross Profit TTM | C$101.5 M |
| Profit Margin | 40.96% |
| Operating Margin | -109.40% |
| Quarterly Revenue Growth | 3.93% |
TerrAscend Corp has the following listings and related stock indices.
Stock: TSX: TSND
Stock: CSE: TER
Stock: FSX: TED
Stock: OTC: TRSSF